FDA Guidance for Industry: Bispecific Antibody Development Programs

Titel:
FDA Guidance for Industry: Bispecific Antibody Development Programs
Internet:

https://www.gmp-navigator.com/files/guidemgr/35086505fnl Bispecific Antibody Development Programs Final Guidance 2019-768.pdf

Herkunft/Verlag:

FDA

Inhalt:
This guidance provides recommendations to assist industry and other parties involved in the development of bispecific antibodies.

Zurück